Genomic DNA and cell division machinery

Genomic DNA and cell division machinery represent the fundamental targets of traditional cytotoxic chemotherapy (National Cancer Institute, 2023). Genomic DNA serves as the blueprint for cellular function and replication, while the cell division machinery, primarily the mitotic spindle and associated proteins like tubulin, facilitates the physical separation of chromosomes during mitosis (StatPearls, 2023). Drugs targeting these components aim to disrupt the rapid proliferation characteristic of malignant cells. DNA-damaging agents like alkylators (e.g., cyclophosphamide) and platinum compounds (e.g., cisplatin) cause structural lesions that trigger apoptosis, while antimetabolites interfere with the synthesis of DNA precursors (American Cancer Society, 2024). Simultaneously, microtubule-targeting agents like taxanes and vinca alkaloids disrupt the assembly or disassembly of the mitotic spindle, leading to cell cycle arrest in the M-phase (Nature Reviews Cancer, 2021). While highly effective against many cancers, these targets are also present in normal rapidly dividing tissues, leading to significant side effects such as bone marrow suppression and hair loss (Mayo Clinic, 2023). Therapeutic challenges include the development of drug resistance and the lack of specificity for cancer cells over healthy proliferating cells (Nature Reviews Cancer, 2021).

Other names

DNA and mitotic machineryGenomic DNA and mitotic spindleCytotoxic chemotherapy targets

Drugs targeting this system act through DNA alkylation, intercalation, topoisomerase inhibition, antimetabolite activity, and microtubule modulation (StatPearls, 2023).